Clinical Trials in Detroit

Showing 4041-4060 of 19,719 trials

Nafamostat Efficacy in Phase 3 Registrational CRRT Study

NCT06150742

A prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at higher risk for bleeding.

Acute Kidney Injury

Talphera, Inc70 participantsStarted Aug 2024

Los Angeles, California, United States • Orlando, Florida, United States • Detroit, Michigan, United States +7 more locations

Active Not Recruiting< 1 mile

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

NCT05064553

The primary objective is to assess overall sensitivity and specificity of Oncoguard™ Liver for hepatocellular cancer (HCC) detection in a surveillance population.

Hepatocellular CarcinomaHepatocellular CancerHepatitis B+2 more

Exact Sciences Corporation2,990 participantsStarted Jul 2021

Chandler, Arizona, United States • Sun City, Arizona, United States • Bakersfield, California, United States +73 more locations

Nafamostat Efficacy in Phase 3 Registrational CRRT Study

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Find Trials by Condition in Detroit

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)

Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma

CemiplimAb Survivorship Epidemiology

Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy

Biliary Atresia Study in Infants and Children

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)

Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)

A Study of LY3841136 in Overweight and Obese Participants

Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations

Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial